Press Release Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 7 hours ago
Press Release Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11 Aug 4
Press Release Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome Aug 3